Infliximab-induced lupus erythematosus in a case of ulcerative colitis

Jun Nishikawa; Takako Miyazaki; Nobuhiro Suzuki; Yuko Itaya; Hidemoto Yamawaki; Hiroshi Mihara; Yushi Hasumoto; Haruka Fujinami; Kohei Ogawa; Ayumu Hosokawa; Takahiko Kudo; Toshiro Sugiyama

Infliximab-induced lupus erythematosus in a case of ulcerative colitis

Jun Nishikawa, Takako Miyazaki, Nobuhiro Suzuki, Yuko Itaya, Hidemoto Yamawaki, Hiroshi Mihara, Yushi Hasumoto, Haruka Fujinami, Kohei Ogawa, Ayumu Hosokawa, Takahiko Kudo, Toshiro Sugiyama^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment While this is a rare complication of infliximab, early diagnosis and successful management are essential.

Original language	English
Pages (from-to)	1535-1539
Number of pages	5
Journal	Journal of Japanese Society of Gastroenterology
Volume	108
Issue number	9
State	Published - 2011/09

ASJC Scopus subject areas

Gastroenterology

Cite this

@article{752935bc331a4f14aec6872e8ea54231,

title = "Infliximab-induced lupus erythematosus in a case of ulcerative colitis",

abstract = "Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment While this is a rare complication of infliximab, early diagnosis and successful management are essential.",

author = "Jun Nishikawa and Takako Miyazaki and Nobuhiro Suzuki and Yuko Itaya and Hidemoto Yamawaki and Hiroshi Mihara and Yushi Hasumoto and Haruka Fujinami and Kohei Ogawa and Ayumu Hosokawa and Takahiko Kudo and Toshiro Sugiyama",

year = "2011",

month = sep,

language = "英語",

volume = "108",

pages = "1535--1539",

journal = "Journal of Japanese Society of Gastroenterology",

issn = "0446-6586",

publisher = "Japanese Society of Gastroenterology",

number = "9",

}

TY - JOUR

T1 - Infliximab-induced lupus erythematosus in a case of ulcerative colitis

AU - Nishikawa, Jun

AU - Miyazaki, Takako

AU - Suzuki, Nobuhiro

AU - Itaya, Yuko

AU - Yamawaki, Hidemoto

AU - Mihara, Hiroshi

AU - Hasumoto, Yushi

AU - Fujinami, Haruka

AU - Ogawa, Kohei

AU - Hosokawa, Ayumu

AU - Kudo, Takahiko

AU - Sugiyama, Toshiro

PY - 2011/9

Y1 - 2011/9

N2 - Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment While this is a rare complication of infliximab, early diagnosis and successful management are essential.

AB - Infliximab is widely used in the treatment of inflammatory bowel disease, but despite its good clinical efficacy and tolerance, drug-induced autoimmune disorders have been reported as adverse reactions and are a matter of concern. Here we report a patient with ulcerative colitis who developed drug-induced lupus erythematosus after infliximab treatment While this is a rare complication of infliximab, early diagnosis and successful management are essential.

UR - http://www.scopus.com/inward/record.url?scp=80053476882&partnerID=8YFLogxK

M3 - 学術論文

C2 - 21891993

AN - SCOPUS:80053476882

SN - 0446-6586

VL - 108

SP - 1535

EP - 1539

JO - Journal of Japanese Society of Gastroenterology

JF - Journal of Japanese Society of Gastroenterology

IS - 9

ER -

Infliximab-induced lupus erythematosus in a case of ulcerative colitis

Abstract

ASJC Scopus subject areas

Fingerprint

Cite this